Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v19-FR | Version v5-FR | |
|---|---|---|
| Language | French | French |
| Date Updated | 2019-10-17 | 2018-12-12 |
| Drug Identification Number | 02080036 | 02080036 |
| Brand name | ETOPOSIDE INJECTION | ETOPOSIDE INJECTION |
| Common or Proper name | ETOPOSIDE | ETOPOSIDE |
| Company Name | TEVA CANADA LIMITED | TEVA CANADA LIMITED |
| Ingredients | ETOPOSIDE | ETOPOSIDE |
| Strength(s) | 20MG | 20MG |
| Dosage form(s) | LIQUID | LIQUID |
| Route of administration | INTRAVENOUS | INTRAVENOUS |
| Packaging size | 10ML | 10ML |
| ATC code | L01CB | L01CB |
| ATC description | PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS | PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS |
| Reason for shortage | Demand increase for the drug. | Demand increase for the drug. |
| Anticipated start date | ||
| Actual start date | 2018-12-04 | 2018-12-04 |
| Estimated end date | 2019-12-31 | 2019-03-30 |
| Actual end date | ||
| Shortage status | Actual shortage | Actual shortage |
| Tier 3 Status | No | No |
| Company comments | Allocating Inventory until next supply (12/31) for 100% of Market. | Will be managing inventory to Market. Demand increase cannot be supported in full but will be working closely to support all demand possible. |
| Health Canada comments |